tiprankstipranks
Trending News
More News >
New Nordic Healthbrands AB (SE:NNH)
:NNH
Sweden Market
Advertisement

New Nordic Healthbrands AB (NNH) AI Stock Analysis

Compare
0 Followers

Top Page

SE:NNH

New Nordic Healthbrands AB

(NNH)

Rating:57Neutral
Price Target:
kr24.00
▲(0.42% Upside)
New Nordic Healthbrands AB's stock score is primarily influenced by its strong financial performance, particularly in revenue growth and production efficiency. However, the stock's valuation is high, with a P/E ratio suggesting it may be overvalued given its current profitability challenges. Technical analysis shows some positive trends, but momentum is limited. The absence of earnings call data and corporate events means these factors do not influence the score.

New Nordic Healthbrands AB (NNH) vs. iShares MSCI Sweden ETF (EWD)

New Nordic Healthbrands AB Business Overview & Revenue Model

Company DescriptionNew Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum, chewing gum, face and eye cream, and dietary supplements. It offers its products under Hair Volume, Skin Care, Beauty In & Out, and New Nordic brand names. The company sells its products through pharmacies, department stores, health stores, travel retailers, and beauty shops, as well as through online stores in 41 countries in North America, Canada, Europe, the United States, and internationally. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
How the Company Makes MoneyNew Nordic Healthbrands AB generates revenue primarily through the sale of its dietary supplements and beauty products. The company's revenue model is centered on its proprietary products, which are distributed globally through a combination of direct-to-consumer sales via its online platform and through partnerships with retailers, pharmacies, and health food stores. Additionally, New Nordic's strategic marketing and brand positioning in the natural health sector contribute significantly to its earnings. The company also leverages its strong brand reputation and extensive distribution network to maintain a steady stream of income.

New Nordic Healthbrands AB Financial Statement Overview

Summary
New Nordic Healthbrands AB exhibits strong revenue growth and efficient production, as evidenced by its high gross profit margin. However, profitability is constrained by low net profit margins and modest EBIT and EBITDA margins. The balance sheet reflects a stable financial position with prudent leverage. Cash flow analysis reveals strong free cash flow growth, though challenges remain in converting earnings to cash. Overall, the company is on a growth trajectory but needs to enhance operational efficiency and cash conversion to improve profitability.
Income Statement
65
Positive
New Nordic Healthbrands AB shows a strong gross profit margin of 64.58% TTM, indicating efficient production and pricing strategies. However, the net profit margin is low at 0.87% TTM, reflecting challenges in controlling operating expenses. Revenue growth is robust at 37.1% TTM, suggesting strong market demand and expansion. Despite this, EBIT and EBITDA margins are modest at 1.80% and 2.30% TTM, respectively, highlighting potential inefficiencies in operations.
Balance Sheet
70
Positive
The company maintains a healthy debt-to-equity ratio of 0.37 TTM, indicating prudent leverage management. Return on equity is modest at 4.95% TTM, suggesting moderate profitability relative to shareholder investments. The equity ratio stands at 40.38% TTM, reflecting a stable capital structure with a significant portion of assets financed by equity.
Cash Flow
60
Neutral
Free cash flow growth is impressive at 71.78% TTM, indicating improved cash generation capabilities. However, the operating cash flow to net income ratio is low at 0.05 TTM, suggesting potential issues in converting earnings into cash. The free cash flow to net income ratio is strong at 71.19% TTM, demonstrating effective cash management relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue566.00M550.31M533.85M487.50M514.85M450.06M
Gross Profit365.53M354.69M348.23M318.50M350.05M309.08M
EBITDA13.00M-1.43M-1.94M-2.57M29.34M24.47M
Net Income4.95M-7.70M-6.19M-2.82M21.30M17.77M
Balance Sheet
Total Assets252.91M248.72M249.06M251.67M238.35M191.49M
Cash, Cash Equivalents and Short-Term Investments9.69M15.25M13.81M10.70M11.88M10.40M
Total Debt37.72M39.22M26.64M48.35M24.43M1.56M
Total Liabilities150.79M148.19M143.03M139.10M118.03M86.68M
Stockholders Equity102.12M100.92M106.03M112.57M120.32M104.81M
Cash Flow
Free Cash Flow5.38M-6.62M25.88M-18.41M-10.58M17.80M
Operating Cash Flow7.56M-5.40M28.03M-15.45M-7.87M19.68M
Investing Cash Flow-3.96M-3.71M-3.40M-2.62M-2.97M-1.17M
Financing Cash Flow-5.75M10.39M-21.17M16.59M12.07M-18.39M

New Nordic Healthbrands AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price23.90
Price Trends
50DMA
22.86
Positive
100DMA
21.16
Positive
200DMA
18.03
Positive
Market Momentum
MACD
0.09
Positive
RSI
49.91
Neutral
STOCH
81.25
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NNH, the sentiment is Positive. The current price of 23.9 is below the 20-day moving average (MA) of 24.30, above the 50-day MA of 22.86, and above the 200-day MA of 18.03, indicating a neutral trend. The MACD of 0.09 indicates Positive momentum. The RSI at 49.91 is Neutral, neither overbought nor oversold. The STOCH value of 81.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:NNH.

New Nordic Healthbrands AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$20.49B14.78-2.88%3.11%1.86%-5.76%
57
Neutral
kr148.07M29.90
3.14%
€105.49M58.620.63%2.68%
€325.08M40.411.69%
kr699.60M46.51
2.20%
77
Outperform
kr529.10M30.68
0.50%19.30%68.77%
76
Outperform
kr696.05M15.32
6.07%8.13%90.46%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:NNH
New Nordic Healthbrands AB
23.90
8.30
53.21%
DE:9KF
Midsona AB Class B
0.67
-0.10
-12.99%
DE:B39
Humble Group AB
0.68
-0.35
-33.98%
SE:SKMO
Skane-moellan AB
63.60
14.25
28.88%
SE:CHEF
Cheffelo AB
56.30
31.34
125.56%
SE:SNX
Premium Snacks Nordic AB
38.90
24.30
166.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025